Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
MEDIUM-CHAIN TRIGLYCERIDES
EPA CPDat observed this chemical in 12 composition records across product categories including Personal care.
Research docs0Claims0Sources22FunctionFunction pendingIdentifierDTXSID301026606
Concern score
Not assessed — no hazard data yet.
How we scored this
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 · limited confidence.
Where it appears
Prevalence of MEDIUM-CHAIN TRIGLYCERIDES in our catalog (epa_cpdat).
Products
12
Brands
6
Personal care
See products using MEDIUM-CHAIN TRIGLYCERIDES →Catalog
Found in these products
Co-occurrence
Often appears with
Ingredients that frequently appear alongside MEDIUM-CHAIN TRIGLYCERIDES in the catalog.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
Evidence read
The published evidence profile currently shaping this ingredient record.
No evidence profiles are attached to this ingredient yet.
Linked research
Primary documents currently linked to this ingredient record.
No linked research documents are attached to this ingredient yet.
Extracted claims
Structured claim signals pulled from linked ingredient research.
No extracted claims are attached to this ingredient yet.
Regulatory status
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 12 composition records across product categories including Personal care.
Effective: July 2015View source →
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Potency: 1.1 %w/v
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 4771 mg
